BioMarck Pharmaceuticals

BioMarck Pharmaceuticals, Ltd. is a privately owned biopharmaceutical company dedicated to the discovery and development of new drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of mucus and pulmonary inflammation in patients with chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis.  WEBSTER VENTURES is an investor in BioMarck Pharmaceuticals.

Webster Ventures Logo


Contact Us

For more information, please call +1 (505) 954-9500, or fill out the form below. Thank you!

Your Name (required):

Your Email (required):

Subject:

Your Message:

captcha
Please type the text in the image above.